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Cinnamaldehyde (CA) has been known to exhibit anti-inﬂammatory and anticancer eﬀects. Although numerous pharmacological
eﬀects have been demonstrated, regulatory eﬀect of CA on the functional activation of monocytes and macrophages has
not been fully elucidated yet. To evaluate its monocyte/macrophage-mediated immune responses, macrophages activated by
lipopolysaccharide(LPS),andmonocytestreatedwithproaggregativeantibodies,andextracellularmatrixproteinﬁbronectinwere
employed. CA was able to suppress both the production of nitric oxide (NO) and upregulation of surface levels of costimulatory
molecules (CD80 and CD69) and pattern recognition receptors (toll-like receptor 2 (TLR2) and complement receptor (CR3)). In
addition, CA also blocked cell-cell adhesion induced by the activation of CD29 and CD43 but not cell-ﬁbronectin adhesion.
Immunoblotting analysis suggested that CA inhibition was due to the inhibition of phosphoinositide-3-kinase (PI3K) and
phosphoinositide-dependent kinase (PDK)1 as well as nuclear factor-(NF-) κB activation. In particular, thiol compounds with
sulphydryl group, L-cysteine and dithiothreitol (DTT), strongly abrogated CA-mediated NO production and NF-κB activation.
Therefore, our results suggest that CA can act as a strong regulator of monocyte/macrophage-mediated immune responses by
thiolation of target cysteine residues in PI3K or PDK1.
1.Introduction
Monocytes/macrophages play a critical role in managing
innate and adaptive immunity-including inﬂammatory pro-
cesses by secreting proinﬂammatory molecules (eg. tumor
necrosis factor (TNF)-α, and nitric oxide (NO)) [1]. The
activation of macrophages and monocytes is mediated by
activation of various receptors including Toll like receptor-
(TLR-) 4 and their counter molecules such as lipopolysac-
charide (LPS) derived from bacteria or virus [2]. In par-
allel, the activation of these cells triggers various cellular
responses such as cell migration, adhesion, extravasation,
and inﬁltration to induce eﬀective movement of these cells
into inﬂamed tissue by adhesion molecules such as β1
(CD18) or β2 (CD29) integrins and their ligands such as
vascular cell adhesion molecule-(VCAM-) 1 or intercellular
adhesionmolecule-(ICAM-)1[3].Themolecularinteraction
between surface receptors and counter molecules seen in
various cellular inﬂammatory responses generates a series
of complex signaling events composed of numerous intra-
cellular enzymes such as phosphoinositide-3-kinase (PI3K),
phosphoinositide-dependent kinase 1 (PDK1), Akt (protein
kinase B), and mitogen-activated protein kinases (MAPKs)
such as extracellular signal-regulated kinase (ERK), c-Jun
N-terminal kinase (JNK), and p38 [4, 5] linked to actin
cytoskeleton rearrangement for modulating cellular activa-
tion or the proinﬂammatory gene expression by mediating
with transcription factors like NF-κB and AP-1 [6]. Recently,2 Mediators of Inﬂammation
inﬂammatory responses by monocytes and macrophages
were reported to be a critical pathological event in triggering
variousacuteorchronicdiseasessuchassepticshock,cancer,
autoimmune diseases, cardiovascular diseases, obesity, and
diabetes [7, 8]. It is therefore considered that development
of promising regulators of monocyte/macrophage-mediated
inﬂammatory responses without side eﬀects could be useful
for prevention of, or as the therapeutic remedy for, various
inﬂammation-mediated diseases [9].
Cinnamaldehyde (CA; Figure 1(a)), a major bioac-
tive compound isolated from the leaves of Cinnamomum
osmophloeum Kaneh [10, 11], has been known to trigger
apoptosis through mitochondrial permeability transition in
human promyelocytic leukemia HL-60 cells [12], by activat-
ing the proapoptotic Bcl-2 family proteins [13]. Treatment
of cultured mouse splenocytes with CA in a dose-dependent
manner blocked the proliferation of lymphocytes induced
by concanavalin A and LPS [14]. This compound was also
found to suppress NF-κB activation within macrophage-like
RAW264.7 cells [15]. It has been demonstrated that CA is
capable of blocking inducible nitric oxide synthase (iNOS)
and NO production by mediation of NF-κBa c t i v a t i o n
blockade in LPS-stimulated RAW264.7 cells [16]. Moreover,
the production of PGE2 was also reduced by CA exposure
in cultured rat cerebral microvascular endothelial cells [17].
These results strongly suggested that CA can be applied as
an anti-inﬂammatory drug. However, the pharmacological
target and inhibitory mechanism of CA, and its activ-
ity on various cellular events such as cell adhesion and
migration commonly seen in the functional activation of
monocytes/macrophages, have not been examined yet. Thus,
in this study, we investigated the detailed regulatory roles of
CA on monocyte/macrophage-mediated immune responses
and its potential target enzyme.
2.MaterialsandMethods
2.1. Materials. CA was kindly supplied from the Aging
Tissue Bank (Pusan National University, Busan, South
Korea). LPS, phorbol 12-myristate 13-acetate (PMA), FITC-
dextran, 1,4-dithiolthreitol (DTT), L-cysteine, and TNF-
α were obtained from Sigma Chemical Co. (St. Louis,
MO). LY294002 and wortmannin and U0126 were from
Calbiochem (La Jolla, CA). RAW264.7 and TLR4-expressing
H E K 2 9 3c e l l sw e r ep u r c h a s e df r o mA m e r i c a nT y p eC u l t u r e
Collection (Rockville, MD) and Invivogen (San Diego,
CA). All other chemicals were purchased from Sigma.
Fibronectin was obtained from BD Biosciences (San Diego,
CA). Phospho-speciﬁc antibodies to p85, PDK1, Akt, and
IκBα were obtained from Cell Signaling (Beverly, MA). Cell-
cell adhesion-inducing antibodies to CD29 (MEM 101A,
puriﬁed IgG1), CD43 (161-46, ascites, IgG1), and P5D2
were used as reported previously [18, 19]. Antibodies
to costimulatory (CD80, CD86, CD40, and CD69) and
adhesion (CD29, CD43, and CD18) molecules were from
BD Biosciences (San Diego, CA). Antibodies to pattern
recognition receptors (dectin-1, TLR2, TLR4, SR, and CR3)
were purchased from Serotec (Raleigh, NC). Suntide, a
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Figure 1: Eﬀect of CA on the viability of RAW264.7 cells. (a)
Chemical structure of CA. (b) The viability of RAW264.7 cells was
determined under the same conditions by MTT assay after 24hour
incubation.
peptide sequence derived from Akt (protein kinase B) [20],
was synthesized by Peptron (Daejeon, South Korea).
2.2. Cell Culture. RAW264.7 and TLR4-expressing HEK293
cells were cultured in RPMI1640 medium supplemented
with 10% heat-inactivated fetal bovine serum (Gibco, Grand
Island, NY), glutamine, and antibiotics (penicillin and
streptomycin), at 37
◦Cw i t h5 %C O 2.
2.3. NO Production. The inhibitory eﬀect of CA on NO
production was determined as previously described [21]. CA
solubilized with DMSO (100%) was diluted with RPMI1640.
RAW264.7 cells (2 × 106 cells/ml) were incubated with
LPS (1μg/ml) in the presence or absence of CA for 24h.
SupernatantswereassayedforNOandTNF-αcontentsusing
Griess reagent.
2.4. Luciferase Reporter Gene Activity Assay. Since RAW264.7
cells are not easily transfected with certain types of DNA
constructs,TLR4-expressingHEK293cells(1 × 106 cells/ml)
were used to be transfected with 1μg of plasmid with NF-κB
and β-galactosidase by using the calcium phosphate method
in a 12-well plate. The cells were used for experiments 48h
aftertransfection.Luciferaseassayswereperformedusingthe
Luciferase Assay System (Promega) [22].
2.5. Determination of Phagocytic Uptake. To measure the
phagocytic activity of RAW264.7 cells, a previously reported
method was used with slight modiﬁcations [23]. RAW264.7
(5 × 104) cells pretreated with CA were resuspended inMediators of Inﬂammation 3
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Figure 2: Eﬀect of CA on the production of NO and surface upregulation of costimulatory molecules and pattern recognition receptors
in LPS-activated RAW264.7 cells. RAW264.7 cells (2 × 106 cells/ml) were incubated with concentrations of CA in the presence of LPS (1
μg/ml) for 24h (NO), 12h (costimulatory molecules and pattern recognition receptors), or 24h (cytoprotective eﬀect). NO levels (a) in
culture supernatant were determined by Griess assay. Surface levels of CD40, CD69, CD80, CD86, dectin-1, TLR2, TLR4, SR, and CR3 were
determined by ﬂow cytometric analysis. The viability of RAW264.7 cells was determined by MTT assay.
∗P <. 05 and
∗∗P <. 01 represent
signiﬁcant diﬀerence compared to LPS alone.4 Mediators of Inﬂammation
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Figure 3: Eﬀect of CA on mRNA levels of inﬂammatory genes in LPS-activated RAW264.7 cells. (a and b) RAW264.7 cells (5×106 cells/ml)
wereincubatedwithCAinthepresenceofLPS(1μg/ml)f o r6h.(a)ThemRN Alev elso fTNF -α,iNOS,IL-1β,andGAPDHweredetermined
by RT-PCR. (b) Relative intensity was determined by densitometric scanning.
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Figure 4: Eﬀect of CA on the upstream signaling pathway for transcriptional activation of NF-κB. (a) TLR-4-expressing HEK293 cells co-
transfected with the plasmid construct, NF-κB-Luc (1κg/ml), and β-gal (as a transfection control) were treated with CA in the presence or
absenceofLPS(1μg/ml)for18h,andluciferaseactivitywasdeterminedbyluminometry.Datarepresentsmean ±SEMofthreeindependent
observations performed in triplicate. (b) RAW264.7 cells (5×106 cells/ml) pretreated with CA for 1h were stimulated with LPS (1κg/ml) for
indicated times. After immunoblotting, the levels of phosphorylated forms of p85, PDK1, Akt, and IκBα were identiﬁed by corresponding
antibodies. The data presented here is from one experiment, representative of three done in total.
∗∗P <. 01 represents signiﬁcant diﬀerence
compared to LPS alone.
100μl PBS containing 1% human serum and incubated with
FITC-dextran (1mg/ml) at 37
◦Ca n d0 ◦C for 30min. The
incubation was stopped by the addition of 2ml ice-cold
PBS containing 1% human serum and 0.02% sodium azide.
The cells were washed three times with cold PBS-azide and
analyzed by ﬂow cytometry.
2.6. Cell-Cell or Cell-Extracellular Matrix Protein (Fi-
bronectin) Adhesion Assay. U937 cell adhesion assay was
performed as previously reported [24, 25]. Brieﬂy, U937 cells
maintained in complete RPMI1640 medium (supplemented
with 100U/ml of penicillin 100 μg/ml of streptomycin, and
10% FBS) were preincubated with CA for 1h at 37
◦C
and further incubated with aggregation-inducing (agonistic)
antibodies (1 μg/ml) in a 96-well plate. After a 50minute
incubation, cell-cell clusters were determined by homotypic
cell-cell adhesion assay using a hemocytometer [24]a n d
analyzed with an inverted light microscope equipped withMediators of Inﬂammation 5
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Figure 5: Eﬀect of CA on the phagocytic uptake of FITC-labeled
dextran. RAW264.7 cells (1 × 106) were incubated with CA in the
presence or absence of 1mg/ml of FITC-labeled dextran for 30min.
The uptake level of dextran was determined by ﬂow cytometric
analysis.
a COHU high-performance CCD (Diavert) video camera.
For the cell-ﬁbronectin adhesion assay, CA-treated U937
cells (5 × 105 cells/well) were seeded on a ﬁbronectin-coated
(50μg/ml) plate and incubated for 3h [26]. After removing
unbound cells with PBS, the attached cells were treated with
0.1% crystal violet for 15min. The OD value at 540nm was
measured by a Spectramax 250 microplate reader.
2.7. Cell Migration (Wound Healing) Assay. RAW264.7 cells
(2 × 106 cells/ml) were incubated with CA for 30min. After
scratching the cultured cells with a pipette, the cells were
further incubated for 48h. The images of the cells in culture
were obtained using an inverted phase contrast microscope
attached to a video camera.
2.8. Flow Cytometry. Surface levels of adhesion molecules
(CD29, CD43, and CD18) in U937 and co-stimulatory
molecules (CD69, CD80, CD40, and CD86) and pattern
recognition receptors (dectin-1, TLR2, TLR4, SR, and CR3)
in RAW264.7 cells were determined by ﬂow cytometric
analysis as reported previously [24]. Stained cells were
analyzed on a FACScan device (Becton-Dickinson, San Jose,
CA).
2.9. MTT Assay. Cell proliferation was measured by 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay as described previously [27].
2.10. Extraction of Total RNA and Semiquantitative RT-
PCR Ampliﬁcation. The total RNA from the CA and LPS-
treated RAW264.7 cells was prepared by adding TRIzol
Reagent (Gibco BRL), according to manufacturer’s proto-
col. Semiquantitative RT reactions were conducted using
MuLV reverse transcriptase as reported previously [28].
The primers (Bioneer, Daejeon, South Korea) were used as
previously reported [29].
2.11. Preparation of Cell Lysates and Immunoblotting.
RAW264.7 cells (5 × 106 cells/ml) were washed 3 times
in cold PBS with 1mM sodium orthovanadate and
lysed in lysis buﬀer (20mM Tris-HCl, pH 7.4, 2mM
EDTA, 2mM ethyleneglycotetraacetic acid, 50mMβ-
glycerophosphate, 1mM sodium orthovanadate, 1mM
dithiothreitol, 1% Triton X-100, 10% glycerol, 10μg/ml
aprotinin, 10μg/ml pepstatin, 1mM benzimide, and 2
mM PMSF) for 30min with rotation at 4◦C. The lysates
were clariﬁed by centrifugation at 16,000 × gf o r1 0m i na t
4◦Ca n ds t o r e da t−20
◦C until needed. Whole cell lysates
were then analyzed by immunoblotting. Proteins were
separated on 10% SDS-polyacrylamide gels and transferred
by electroblotting to polyvinylidene diﬂuoride (PVDF)
membrane. Membranes were blocked for 60min in Tris-
buﬀered saline containing 3% bovine serum albumin,
20mM NaF, 2mM EDTA, and 0.2% Tween 20 at room
temperature. The membrane was incubated for 60min with
speciﬁc primary antibody at 4◦C, washed 3 times with the
same buﬀer, and incubated for additional 60min with horse
radish peroxidase-(HRP-) conjugated secondary antibody.
The total and phosphorylated levels of p85, PDK1, Akt,
IκBα,a n dβ-actin were visualized using the ECL system
(Amersham, Little Chalfont, Buckinghamshire, UK).
2.12. Matrix-Assisted Laser Desorption Ionization Time-of-
Flight Mass Spectrometry (MALDITOF/MS). α Cyano-4-
hydroxycinnamic acid (20mg) (Bruker Daltonics, Bremen,
Germany) was dissolved in 1ml acetone : ethanol (1 : 2,
v/v), and 0.5μl of the matrix solution was mixed with
an equivalent volume of sample. Analysis was performed
using an Ultraﬂex TOF/TOF system (Bruker Daltonics). The
Ultraﬂex TOF/TOF system was operated in positive ion
reﬂect mode. Each spectrum was the cumulative average of
250–450 laser shots. Mass spectra were ﬁrst calibrated in the
closed external mode using the peptide calibration standard
II(BrukerDaltonics),sometimesusingtheinternalstatistical
mode to achieve maximum calibration mass accuracy.
2.13. Statistical Analysis. The Student’s t-test and one–way
ANOVA were used to determine the statistical signiﬁcance
between values of the various experimental and control
groups. P values of .05 or less were considered to be
statistically signiﬁcant.
3. Results and Discussion
Monocytes/macrophages are the prime immune cells man-
aging inﬂammatory responses, which contribute to devel-
opment of number of diseases such as cancer, diabetes, and
atherosclerosis [30, 31]. This view led us to develop novel
immunoregulatory drugs based on the functional activation
of monocytes and macrophages without side eﬀects to
prevent such diseases. In this context, medicinal plants that
have traditionally been used for long time are considered
as attractive biopharmaceutical candidates. With this goal,
therefore, we have attempted to develop macrophage func-
tion regulators using naturally occurring compounds or
plants for a decade.6 Mediators of Inﬂammation
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Figure 6: Eﬀect of CA on cell-cell adhesion and cell-ﬁbronectin adhesion. U937 cells pretreated with CA for 1h were incubated in the
presence or absence of anti-CD29 antibody MEM101A (1 μg/ml) or anti-CD43 antibody 161-46 (1μg/ml). Images (a) of the cells in
culture were obtained using an inverted phase contrast microscope attached to a video camera. Quantitative analysis (b) of cell-cell clusters
was assessed using a quantitative cell-cell adhesion assay. (c) U937 cells pretreated with CA, P5D2, or U0126 for 30min were seeded on
ﬁbronectin-coated (50μg/ml) plates and further incubated for 3h. The number of attached cells was determined by crystal violet assay. (d)
U937 cells (1 ×106cells/ml) were incubated with CA for 12h. Surface levels of CD29, CD18, and CD43 were determined by ﬂow cytometric
analysis.(e)RAW264.7cells(2×106 cells/ml)pretreatedwithCAfor1hwereincubatedfor48hafterscratchingwithapipette.Imagesofthe
cells in culture were obtained using an inverted phase contrast microscope attached to a video camera.
∗P <. 05 and
∗∗P <. 01 represent
signiﬁcant diﬀerence compared to control.
The regulatory eﬀect of CA on LPS-induced macrophage
immune responses was initially examined. Upon nontoxic
concentrations (0 to 40μM) (Figure 1(b)), CA strongly sup-
pressed the production of NO (Figure 2(a)) and the surface
upregulation of costimulatory (CD80 and CD69) and pat-
tern recognition (TLR2 and CR3) molecules (Figure 2(b)).
Moreover, CA protected cells from LPS-induced cytotoxi-
city and apoptosis, mainly induced by the NO producedMediators of Inﬂammation 7
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Figure 7:EﬀectofthiolcompoundsonCAinhibitionofNOproductionandNF-κB-mediatedluciferaseactivity.(a)RAW264.7cells(2×106
cells/ml) pretreated with L-cysteine for 30min were incubated with indicated concentrations of CA in the presence of LPS (1μg/ml) for 24
hours. NO levels in culture supernatant were determined by Griess assay. (b) TLR-4-expressing HEK293 cells cotransfected with the plasmid
construct, NF-μB-Luc (1μg/ml), and β-gal (as a transfection control) were treated with CA, L-cysteine or DTT in the presence or absence
of TNF-μ, PMA, or LPS for 18h where luciferase activity was determined by luminometry. (c) CA and Suntide were incubated in kinase
assay buﬀer for 30min. The adduct was then identiﬁed by MALDITOF/MS analysis.
∗∗P <. 01 and #P <. 05 represent signiﬁcant diﬀerence
compared to control or CA groups.
(Figure 2(c)). The inhibition of NO release occurred at
the transcriptional levels, according to Figure 3.T h u s ,
CA blocked mRNA expression of iNOS as well as other
proinﬂammatory cytokines such as TNF-α and IL-1β as
much as 80 to 95% (Figure 3). Because transcriptional
downregulation of inﬂammatory mediators by CA has been
reported to inhibit NF-κBa c t i v a t i o n[ 16, 32], reporter gene
assay for NF-κB and immunoblotting analysis of upstream
signaling were further conducted. As Figure 4(a) shows, CA
blocked NF-κB-mediated luciferase activity induced by LPS
treatment, similar to previous papers [15, 32]. Interestingly,
CA also blocked a series of NF-κB activation signaling
pathways. This compound suppressed the phosphorylation
of IκBα, Akt, and PDK1 but not p85, a regulatory subunit
of PI3K (Figure 4(b)), suggesting that the pharmacological
target of CA may be PI3K or PDK1 in LPS-mediated
macrophageimmuneresponses.UnlikeLPS-inducedinﬂam-
matory responses, FITC-dextran-induced phagocytic uptake
of RAW264.7 cells, a major response found in innate
immunity, was not negatively modulated by this compound8 Mediators of Inﬂammation
(Figure 5), which suggests that CA cannot regulate all
macrophage functions but modulates mostly LPS-mediated
immune responses in macrophages.
Meanwhile, CA also strongly suppressed cell-cell adhe-
sions induced by proaggregative antibodies to CD29 and
CD43 up to 85% (Figures 6(a) and 6(b)). However, adhesion
of U937 cells to ﬁbronectin, an extracellular matrix protein
acting as a CD29 ligand, was not suppressed by this
compound (Figure 6(c)), indicating that adhesion between
cells but not cell and extracellular matrix could be blocked
by CA. However, CA did not suppress the surface levels of
adhesion molecules such as CD18, CD29, and CD43 even at
40μM( Figure 6(d)), while CA diminished the migration of
RAW264.7cellsinaninvitrowoundhealingassay,compared
to normal (Figure 6(e)). Considering that cell-ﬁbronectin
adhesion only requires simple activation of CD29, and
while intracellular signaling (ERK, p38, and protein kinase
Cδ) and actin cytoskeleton change are important factors in
cell-cell adhesion events [24, 25], CA seems to modulate
intracellular signaling events rather than the blockade of
a direct interaction between CD29 and ﬁbronectin. In
particular, these signaling events targeted to CA seem to
be involved in modulating cell migration commonly seen
in both cell-cell adhesion (Figure 6(a)) and wound healing
assays (Figure 6(e)). CD29-mediated cell-cell adhesion is
an essential phenomenon for survival and activation of
immune cells, particular for an interaction between antigeny
presenting cells (APC) and T lymphocytes or NK cells.
Therefore, antiaggregative eﬀect of CA may contribute
to the regulation of monocyte/macrophage roles as APC
requiring their adhesion responses. Similarly, since PI3K/Akt
inhibition by LY294002 and wortmannin suppressed CD29-
mediated cell-cell adhesion, CA inhibition of adhesion and
migration events seems to occur at the level of PI3K/PDK1,
as in the case of LPS signaling.
Since thiol compounds such as DTT and L-cysteine are
reported to block CA inhibition [16], we ﬁnally examined
whether this pattern can be observed under the same con-
ditions. As expected, pretreatment of L-cysteine (200μM) or
DTT(300μM)beforeCAtreatmentabrogatedtheinhibitory
activity of CA in both NO production (Figure 7(a))a n d
NF-κB-mediated luciferase activity (Figure 7(b)), suggesting
that thiolation is the major chemical mechanism of CA
inhibition. Up to date, we have not been able to locate
the exact thiolation site on the target protein by CA.
However, recent ﬁndings revealing that an adduct formation
of hydroquinone with the sulfhydryl group of Cys-310 in Akt
isabletoblockthephosphorylationofbothThr-308andSer-
473 [33] seem to suggest that a target cysteine sequence of
PI3K or PDK1 can serve as a thiolation site aﬀecting their
phosphorylation and activation. Indeed, we failed to detect
an adduct formation between CA and Suntide, a peptide
fragment containing Cysteine-310 designed according to Akt
amino acid sequence (Figure 7(c)). Because identiﬁcation of
CA target thiolation site is an important step to understand
the exact molecular mechanism of CA inhibition, we are
currently undertaking further analysis using other peptide
sequences containing cysteine residues from PI3K and
PDK1.
In conclusion, we found that CA was able to suppress
the production of NO and upregulation of surface levels of
costimulatory molecules such as the surface upregulation
of both costimulatory (CD80 and CD69) and pattern
recognition molecules (TLR2 and CR3). In addition, CA also
blockedbothcellmigrationandcell-celladhesioninducedby
CD29 and CD43, but not cell-ﬁbronectin adhesion. The CA
inhibitionwaslikelyduetotheinhibitionofPI3KandPDK1,
important for NF-κB activation of signaling components,
according to immunoblotting analysis. In particular, L-
cysteine and DTT strongly interfered CA-mediated inhibition
of NO production and NF-κB activation. Therefore, our
results suggest that CA can act as a strong regulator of
monocyte/macrophage-mediated immune responses, possi-
bly by the induction of thiolation at cysteine residues in
the target enzyme (PDK1 or PI3K). To prove a detailed
inhibitory mechanism, identiﬁcation of molecular targets of
CA will be investigated in our next series of experiments.
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